Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16


Modulatory effects of bovine seminal plasma on uterine inflammatory processes.

Aloé S, Weber F, Behr B, Sauter-Louis C, Zerbe H.

Reprod Domest Anim. 2012 Feb;47(1):12-9. doi: 10.1111/j.1439-0531.2011.01792.x. Epub 2011 Apr 30.


Sitilo experience on peritoneal carcinomatosis from colorectal cancer: clinical prognostic features.

Cavaliere F, Perri P, Rossi CR, Pilati PL, De Simone M, Vaira M, Deraco M, Aloe S, Di Filippo S, Di Filippo F.

J Exp Clin Cancer Res. 2003 Dec;22(4 Suppl):29-33.


Prognostic value of soluble P-selectin levels in colorectal cancer.

Ferroni P, Roselli M, Martini F, D'Alessandro R, Mariotti S, Basili S, Spila A, Aloe S, Palmirotta R, Maggini A, Del Monte G, Mancini R, Graziano F, Cosimelli M, Guadagni F.

Int J Cancer. 2004 Sep 1;111(3):404-8.


Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients.

Guadagni F, Ferroni P, Basili S, Facciolo F, Carlini S, Crecco M, Martini F, Spila A, D'Alessandro R, Aloe S, Cerasoli V, Del Monte G, Mariotti S, Mineo TC, Roselli M.

Lung Cancer. 2004 Jun;44(3):303-10.


Soluble CD40 ligand plasma levels in lung cancer.

Roselli M, Mineo TC, Basili S, Martini F, Mariotti S, Aloe S, Del Monte G, Ambrogi V, Spila A, Palmirotta R, D'Alessandro R, Davì G, Guadagni F, Ferroni P.

Clin Cancer Res. 2004 Jan 15;10(2):610-4.


Association between serum carcinoembryonic antigen and endothelial cell adhesion molecules in colorectal cancer.

Roselli M, Guadagni F, Martini F, Spila A, Mariotti S, D'Alessandro R, Aloe S, Gazzaniga PP, Basili S, Cosimelli M, Ferroni P.

Oncology. 2003;65(2):132-8.


Prognostic value of serum and tumor tissue CA 72-4 content in gastric cancer.

Aloe S, D'Alessandro R, Spila A, Ferroni P, Basili S, Palmirotta R, Carlini M, Graziano F, Mancini R, Mariotti S, Cosimelli M, Roselli M, Guadagni F.

Int J Biol Markers. 2003 Jan-Mar;18(1):21-7.


Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer.

D'Alessandro R, Roselli M, Ferroni P, Mariotti S, Spila A, Aloe S, Carone MD, Abbolito MR, Carlini S, Perri P, Ricciotti A, Botti C, Conti F, Vici P, Chiappetta NR, Cognetti F, Buonomo O, Guadagni F.

Breast Cancer Res Treat. 2001 Jul;68(1):9-19.


Effects of isolated limb perfusion with tumor necrosis factor-alpha on circulating levels of proinflammatory cytokines.

Ferroni P, Di Filippo F, Martini F, Spila A, D'Alessandro T, Cavaliere F, Anzà M, Garinei R, Aloe S, Carone MD, Gazzaniga PP, Guadagni F.

J Immunother. 2001 Jul-Aug;24(4):354-62.


A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study.

Guadagni F, Ferroni P, Carlini S, Mariotti S, Spila A, Aloe S, D'Alessandro R, Carone MD, Cicchetti A, Ricciotti A, Venturo I, Perri P, Di Filippo F, Cognetti F, Botti C, Roselli M.

Clin Cancer Res. 2001 Aug;7(8):2357-62.


Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation.

Spila A, Ferroni P, Cosimelli M, D'Alessandro R, Abbolito MR, Mariotti S, Aloe S, Carone MD, Graziano F, Tedesco M, Martini F, Mancini R, Stigliano V, Roselli M, Guadagni F.

Anticancer Res. 2001 Mar-Apr;21(2B):1263-70.


Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.

Guadagni F, Kantor J, Aloe S, Carone MD, Spila A, D'Alessandro R, Abbolito MR, Cosimelli M, Graziano F, Carboni F, Carlini S, Perri P, Sciarretta F, Greiner JW, Kashmiri SV, Steinberg SM, Roselli M, Schlom J.

Cancer Res. 2001 Mar 15;61(6):2523-32.


CA 19-9 monosialoganglioside content of human colorectal tumor cells correlates with tumor cell-induced platelet aggregation.

Martini F, Guadagni F, Lenti L, D'Alessandro R, Aloe S, Roselli M, Gazzaniga PP, Ferroni P.

Anticancer Res. 2000 May-Jun;20(3A):1609-14.


Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancer.

Spila A, Ferroni P, Cosimelli M, D'Alessandro R, Carone MD, Aloe S, Tedesco M, Mancini R, Casale V, Carlini S, Casciani CU, Roselli M, Guadagni F.

Anticancer Res. 1999 Mar-Apr;19(2B):1363-8.


Overexpression of transforming growth factor beta-type II receptor reduces tumorigenicity and metastastic potential of K-ras-transformed thyroid cells.

Turco A, Coppa A, Aloe S, Baccheschi G, Morrone S, Zupi G, Colletta G.

Int J Cancer. 1999 Jan 5;80(1):85-91.


Levels of expression of hRPB11, a core subassembly subunit of human RNA polymerase II, affect doxorubicin sensitivity and cellular differentiation.

Bruno T, Leonetti C, Aloe S, Iacobini C, Floridi A, Di Tondo U, Punturieri A, Fanciulli M.

FEBS Lett. 1998 May 8;427(2):241-6.

Supplemental Content

Support Center